Issues related to the Pandemic and All-Hazards Preparedness Act (P.L. 109-417)(PAHPA) reauthorization; Issues related to the pharmaceutical supply chain, drug shortages, advanced manufacturing, and pharmaceutical standards.
2025 · 1st Quarter (Jan 1 - Mar 31)
UNITED STATES PHARMACOPEIAL CONVENTION
Filed by AKIN GUMP STRAUSS HAUER & FELD.
Open official filingSource-reported fields
Filing overview
- Type
- 1st Quarter - Report
- Posted
- Apr 21, 2025
- Income
- $50,000.00
- Expenses
- Not reported
- Registrant
- AKIN GUMP STRAUSS HAUER & FELD
- Filing UUID
- 30d0d469-13d7-4a24-b611-12466bf7afe5
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Issues related to pharmaceutical supply chains, drug quality, and drug testing.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.